Beneficient (BENF): Nasdaq/NYSE listing notice — Beneficient receives Nasdaq notice of non-compliance with $1.00 bid price requirement

Beneficient

Received Nasdaq deficiency notice on Nov 28, 2023; 180-day cure period until May 28, 2024.
Closing bid price of Class A common stock (BENF) below $1.00 for 30 consecutive business days.
Company evaluating options including reverse stock split to regain compliance.
Stock continues trading on Nasdaq Global Market under symbol BENF during cure period.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Beneficient received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(1)

Exact text from the filing

November 28, 2023, Beneficient (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the previous 30 consecutive business days, the closing bid price for the Company’s Class A common stock, par value $0.001 per share (the “Class A Common Stock”), had been below the minimum $1.00 per share required for continued listing on The Nasdaq Global Market under Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”). The Notice has no effect at this time on the Class A Comm

View on SEC.gov

Browse all listing & compliance notices →

Beneficient filing history →

Source: SEC EDGAR

accession 0001193125-23-287454

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.